Lineage Cell Therapeutics is a clinical-stage biotechnology enterprise specializing in the development of novel cellular therapies. The company utilizes its proprietary technology platform to generate specific, functional human cells—including oligodendrocyte progenitors, retinal pigment epithelium, and neural cells—designed to replace or support tissues damaged by degenerative diseases, trauma, and chronic medical conditions.